These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 34566888)

  • 1. Imaging-Based Body Fat Distribution in Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis.
    Zhu S; Li Z; Hu C; Sun F; Wang C; Yuan H; Li Y
    Front Endocrinol (Lausanne); 2021; 12():697223. PubMed ID: 34566888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of regional fat mass measurement by whole body DXA scans and anthropometric measures to predict insulin resistance in women with polycystic ovary syndrome and controls.
    Glintborg D; Petersen MH; Ravn P; Hermann AP; Andersen M
    Acta Obstet Gynecol Scand; 2016 Nov; 95(11):1235-1243. PubMed ID: 27529295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual-energy X-ray absorptiometry and adiposity index are sensitive methods to evaluate central fat accumulation in women with polycystic ovary syndrome and normal body mass index.
    Kogure GS; Ribeiro VB; Mendes MC; Ferriani RA; Furtado CLM; Dos Reis RM
    Arch Endocrinol Metab; 2023 May; 67(5):e000627. PubMed ID: 37249458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abdominal fat quantity and distribution in women with polycystic ovary syndrome and extent of its relation to insulin resistance.
    Carmina E; Bucchieri S; Esposito A; Del Puente A; Mansueto P; Orio F; Di Fede G; Rini G
    J Clin Endocrinol Metab; 2007 Jul; 92(7):2500-5. PubMed ID: 17405838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Central arterial stiffness and diastolic dysfunction are associated with insulin resistance and abdominal obesity in young women but polycystic ovary syndrome does not confer additional risk.
    Rees E; Coulson R; Dunstan F; Evans WD; Blundell HL; Luzio SD; Dunseath G; Halcox JP; Fraser AG; Rees DA
    Hum Reprod; 2014 Sep; 29(9):2041-9. PubMed ID: 25035436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The resting metabolic rate in women with polycystic ovary syndrome and its relation to the hormonal milieu, insulin metabolism, and body fat distribution: a cohort study.
    Romualdi D; Versace V; Tagliaferri V; De Cicco S; Immediata V; Apa R; Guido M; Lanzone A
    J Endocrinol Invest; 2019 Sep; 42(9):1089-1097. PubMed ID: 30847861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating kisspeptin and anti-müllerian hormone levels, and insulin resistance in women with polycystic ovary syndrome: A systematic review, meta-analysis, and meta-regression.
    Pérez-López FR; Ornat L; López-Baena MT; Santabárbara J; Savirón-Cornudella R; Pérez-Roncero GR
    Eur J Obstet Gynecol Reprod Biol; 2021 May; 260():85-98. PubMed ID: 33744505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Visceral adiposity and inflammatory bowel disease.
    Rowan CR; McManus J; Boland K; O'Toole A
    Int J Colorectal Dis; 2021 Nov; 36(11):2305-2319. PubMed ID: 34104989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of lifestyle modifications on anthropometric, clinical, and biochemical parameters in adolescent girls with polycystic ovary syndrome: a systematic review and meta-analysis.
    Abdolahian S; Tehrani FR; Amiri M; Ghodsi D; Yarandi RB; Jafari M; Majd HA; Nahidi F
    BMC Endocr Disord; 2020 May; 20(1):71. PubMed ID: 32429890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Global adiposity and thickness of intraperitoneal and mesenteric adipose tissue depots are increased in women with polycystic ovary syndrome (PCOS).
    Borruel S; Fernández-Durán E; Alpañés M; Martí D; Alvarez-Blasco F; Luque-Ramírez M; Escobar-Morreale HF
    J Clin Endocrinol Metab; 2013 Mar; 98(3):1254-63. PubMed ID: 23386652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of fat to lean mass ratio with metabolic dysfunction in women with polycystic ovary syndrome.
    Ezeh U; Pall M; Mathur R; Azziz R
    Hum Reprod; 2014 Jul; 29(7):1508-17. PubMed ID: 24813197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PCOS is associated with increased CD11c expression and crown-like structures in adipose tissue and increased central abdominal fat depots independent of obesity.
    Huang ZH; Manickam B; Ryvkin V; Zhou XJ; Fantuzzi G; Mazzone T; Sam S
    J Clin Endocrinol Metab; 2013 Jan; 98(1):E17-24. PubMed ID: 23118428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The evaluation of carotid intima-media thickness and visceral obesity as an atherosclerosis predictor in newly-diagnosed polycystic ovary syndrome.
    Buyukkaya R; Besir FH; Yazgan S; Karatas A; Kose SA; Aydin Y; Erdogmus B
    Clin Ter; 2014; 165(1):e6-11. PubMed ID: 24589963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peri-muscular adipose tissue may play a unique role in determining insulin sensitivity/resistance in women with polycystic ovary syndrome.
    Morrison SA; Goss AM; Azziz R; Raju DA; Gower BA
    Hum Reprod; 2017 Jan; 32(1):185-192. PubMed ID: 27827322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lean muscle mass in classic or ovulatory PCOS: association with central obesity and insulin resistance.
    Mario FM; do Amarante F; Toscani MK; Spritzer PM
    Exp Clin Endocrinol Diabetes; 2012 Oct; 120(9):511-6. PubMed ID: 22576259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Visceral adiposity index levels in overweight and/or obese, and non-obese patients with polycystic ovary syndrome and its relationship with metabolic and inflammatory parameters.
    Durmus U; Duran C; Ecirli S
    J Endocrinol Invest; 2017 May; 40(5):487-497. PubMed ID: 27838846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Body fat composition and distribution in women with polycystic ovary syndrome.
    Cosar E; Uçok K; Akgün L; Köken G; Sahin FK; Arioz DT; Baş O
    Gynecol Endocrinol; 2008 Aug; 24(8):428-32. PubMed ID: 18850379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prenatal androgen excess negatively impacts body fat distribution in a nonhuman primate model of polycystic ovary syndrome.
    Bruns CM; Baum ST; Colman RJ; Dumesic DA; Eisner JR; Jensen MD; Whigham LD; Abbott DH
    Int J Obes (Lond); 2007 Oct; 31(10):1579-85. PubMed ID: 17471299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Asprosin levels in women with and without the polycystic ovary syndrome: a systematic review and meta-analysis.
    Pérez-López FR; López-Baena MT; Pérez-Roncero GR; Chedraui P; Varikasuvu SR; García-Alfaro P
    Gynecol Endocrinol; 2023 Dec; 39(1):2152790. PubMed ID: 36480935
    [No Abstract]   [Full Text] [Related]  

  • 20. Subcutaneous adipose tissue topography and metabolic disturbances in polycystic ovary syndrome.
    Wehr E; Möller R; Horejsi R; Giuliani A; Kopera D; Schweighofer N; Groselj-Strele A; Pieber TR; Obermayer-Pietsch B
    Wien Klin Wochenschr; 2009; 121(7-8):262-9. PubMed ID: 19562283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.